Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscular Diseases | 3 | 2023 | 556 | 1.740 |
Why?
|
Muscle, Skeletal | 16 | 2023 | 4931 | 1.690 |
Why?
|
Regeneration | 8 | 2023 | 1485 | 1.630 |
Why?
|
Satellite Cells, Skeletal Muscle | 3 | 2023 | 124 | 1.190 |
Why?
|
Musculoskeletal Physiological Phenomena | 1 | 2023 | 30 | 0.920 |
Why?
|
Rhytidoplasty | 1 | 2024 | 60 | 0.900 |
Why?
|
Burns | 10 | 2018 | 1815 | 0.900 |
Why?
|
Tissue Scaffolds | 5 | 2023 | 956 | 0.810 |
Why?
|
Mammaplasty | 6 | 2023 | 1204 | 0.810 |
Why?
|
Muscle Development | 6 | 2020 | 271 | 0.780 |
Why?
|
Sarcopenia | 3 | 2023 | 368 | 0.770 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2020 | 38 | 0.760 |
Why?
|
Mastectomy | 4 | 2023 | 1793 | 0.760 |
Why?
|
Skin Transplantation | 5 | 2018 | 1074 | 0.740 |
Why?
|
Fibrosis | 6 | 2023 | 2029 | 0.720 |
Why?
|
Surgical Wound Infection | 3 | 2018 | 1540 | 0.700 |
Why?
|
Guided Tissue Regeneration | 1 | 2019 | 85 | 0.680 |
Why?
|
Aortic Aneurysm, Abdominal | 8 | 2006 | 1186 | 0.650 |
Why?
|
Occlusive Dressings | 1 | 2018 | 50 | 0.650 |
Why?
|
Quadriceps Muscle | 1 | 2019 | 144 | 0.640 |
Why?
|
Surgical Flaps | 7 | 2023 | 1640 | 0.630 |
Why?
|
Breast Implantation | 2 | 2017 | 218 | 0.600 |
Why?
|
Chitosan | 1 | 2018 | 141 | 0.590 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2023 | 2015 | 0.590 |
Why?
|
Matrix Metalloproteinase 9 | 7 | 2006 | 638 | 0.570 |
Why?
|
Contracture | 2 | 2016 | 223 | 0.540 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2023 | 3508 | 0.540 |
Why?
|
Matrix Metalloproteinase 2 | 4 | 2006 | 472 | 0.510 |
Why?
|
Wound Healing | 5 | 2021 | 2785 | 0.510 |
Why?
|
Facial Transplantation | 4 | 2021 | 226 | 0.490 |
Why?
|
Parabiosis | 1 | 2014 | 65 | 0.490 |
Why?
|
Pancreatic Elastase | 6 | 2006 | 136 | 0.430 |
Why?
|
Cartoons as Topic | 1 | 2011 | 17 | 0.400 |
Why?
|
Osteosarcoma | 1 | 2016 | 881 | 0.360 |
Why?
|
Recovery of Function | 2 | 2019 | 2925 | 0.350 |
Why?
|
Aging | 6 | 2023 | 8664 | 0.340 |
Why?
|
Glycosaminoglycans | 2 | 2023 | 624 | 0.320 |
Why?
|
Tissue Engineering | 4 | 2023 | 1880 | 0.300 |
Why?
|
Cell Cycle | 1 | 2016 | 2967 | 0.300 |
Why?
|
Child Welfare | 1 | 2011 | 523 | 0.290 |
Why?
|
Animals | 36 | 2023 | 168757 | 0.290 |
Why?
|
Muscle Fibers, Skeletal | 5 | 2018 | 555 | 0.280 |
Why?
|
Rats, Sprague-Dawley | 9 | 2023 | 8301 | 0.280 |
Why?
|
Nitroso Compounds | 1 | 2006 | 72 | 0.270 |
Why?
|
Gene Expression Profiling | 4 | 2020 | 9438 | 0.270 |
Why?
|
Breast | 1 | 2015 | 1969 | 0.270 |
Why?
|
Testosterone | 2 | 2014 | 2420 | 0.270 |
Why?
|
Nitric Oxide Donors | 1 | 2006 | 121 | 0.270 |
Why?
|
Facial Injuries | 2 | 2017 | 183 | 0.270 |
Why?
|
Mice | 20 | 2023 | 81183 | 0.250 |
Why?
|
Health Education | 1 | 2011 | 1056 | 0.240 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2006 | 1213 | 0.240 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2023 | 772 | 0.240 |
Why?
|
Muscle Strength | 2 | 2019 | 592 | 0.240 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 597 | 0.240 |
Why?
|
Adipose Tissue | 1 | 2016 | 3279 | 0.230 |
Why?
|
Cell Movement | 4 | 2018 | 5217 | 0.230 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2529 | 0.230 |
Why?
|
Cell Proliferation | 2 | 2017 | 10481 | 0.230 |
Why?
|
Organ Size | 3 | 2019 | 2252 | 0.220 |
Why?
|
Collagen | 2 | 2023 | 2689 | 0.220 |
Why?
|
Rats | 11 | 2023 | 24260 | 0.220 |
Why?
|
Metalloendopeptidases | 1 | 2004 | 396 | 0.220 |
Why?
|
Brain Neoplasms | 1 | 2024 | 8863 | 0.210 |
Why?
|
Dissection | 1 | 2024 | 295 | 0.210 |
Why?
|
Mice, Inbred C57BL | 7 | 2023 | 21827 | 0.210 |
Why?
|
Porosity | 1 | 2023 | 362 | 0.210 |
Why?
|
India | 5 | 2016 | 2197 | 0.200 |
Why?
|
Surgery, Plastic | 3 | 2016 | 624 | 0.200 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 379 | 0.200 |
Why?
|
Estrogen Receptor beta | 1 | 2022 | 175 | 0.200 |
Why?
|
Breast Neoplasms | 7 | 2023 | 20822 | 0.200 |
Why?
|
Wounds and Injuries | 3 | 2021 | 2400 | 0.180 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2006 | 686 | 0.170 |
Why?
|
Health Promotion | 1 | 2011 | 2205 | 0.170 |
Why?
|
Physical Therapy Modalities | 1 | 2023 | 550 | 0.170 |
Why?
|
Skin Pigmentation | 1 | 2021 | 282 | 0.170 |
Why?
|
Neuromuscular Junction | 1 | 2021 | 398 | 0.170 |
Why?
|
Hematoma | 1 | 2024 | 758 | 0.170 |
Why?
|
Leukocytes | 1 | 2006 | 2043 | 0.160 |
Why?
|
Ischemic Preconditioning | 1 | 2018 | 92 | 0.160 |
Why?
|
Estrogen Receptor alpha | 1 | 2022 | 577 | 0.160 |
Why?
|
Replantation | 1 | 2018 | 148 | 0.150 |
Why?
|
Rectus Abdominis | 2 | 2023 | 97 | 0.150 |
Why?
|
Wakefulness | 1 | 2024 | 1245 | 0.140 |
Why?
|
Lymphedema | 1 | 2023 | 534 | 0.140 |
Why?
|
Thyroid Hormone Receptors alpha | 1 | 2016 | 14 | 0.140 |
Why?
|
Keratinocytes | 2 | 2018 | 798 | 0.140 |
Why?
|
Fetus | 2 | 2014 | 1880 | 0.140 |
Why?
|
Sex Characteristics | 1 | 2006 | 2585 | 0.140 |
Why?
|
Pentylenetetrazole | 1 | 2016 | 69 | 0.140 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2016 | 62 | 0.140 |
Why?
|
Nutritional Requirements | 1 | 2017 | 286 | 0.130 |
Why?
|
Organ Preservation | 1 | 2018 | 331 | 0.130 |
Why?
|
Oxidative Stress | 1 | 2006 | 3086 | 0.130 |
Why?
|
Transplantation, Homologous | 4 | 2021 | 4776 | 0.130 |
Why?
|
rho-Associated Kinases | 1 | 2016 | 279 | 0.130 |
Why?
|
Disease Models, Animal | 7 | 2018 | 18029 | 0.130 |
Why?
|
Hypertrophy | 2 | 2014 | 569 | 0.120 |
Why?
|
Aorta, Abdominal | 3 | 2006 | 646 | 0.120 |
Why?
|
Time Factors | 6 | 2018 | 40075 | 0.120 |
Why?
|
Signal Transduction | 5 | 2023 | 23403 | 0.120 |
Why?
|
Graft Survival | 4 | 2018 | 3737 | 0.120 |
Why?
|
Transplantation, Autologous | 2 | 2018 | 2124 | 0.120 |
Why?
|
Humans | 41 | 2024 | 744343 | 0.120 |
Why?
|
Breast Implants | 1 | 2017 | 387 | 0.120 |
Why?
|
Diseases in Twins | 1 | 2015 | 449 | 0.120 |
Why?
|
Stem Cells | 3 | 2023 | 3567 | 0.120 |
Why?
|
Thyroid Hormones | 1 | 2016 | 390 | 0.110 |
Why?
|
Neutrophil Infiltration | 2 | 2006 | 390 | 0.110 |
Why?
|
Wrist Injuries | 1 | 2015 | 208 | 0.110 |
Why?
|
Bronchodilator Agents | 1 | 2016 | 502 | 0.110 |
Why?
|
Hand Injuries | 1 | 2015 | 242 | 0.110 |
Why?
|
Extremities | 1 | 2018 | 865 | 0.110 |
Why?
|
Apoptosis | 3 | 2022 | 9727 | 0.110 |
Why?
|
Kerosene | 1 | 2012 | 15 | 0.110 |
Why?
|
Graft Rejection | 3 | 2021 | 4397 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2016 | 12072 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1071 | 0.110 |
Why?
|
Mitochondria | 1 | 2005 | 3520 | 0.110 |
Why?
|
Cells, Cultured | 9 | 2018 | 19229 | 0.100 |
Why?
|
Enzyme Activation | 3 | 2009 | 3701 | 0.100 |
Why?
|
West Virginia | 1 | 2011 | 28 | 0.100 |
Why?
|
Anti-Asthmatic Agents | 1 | 2016 | 536 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1401 | 0.100 |
Why?
|
Male | 24 | 2023 | 350118 | 0.100 |
Why?
|
Enteral Nutrition | 1 | 2017 | 763 | 0.100 |
Why?
|
Cytokines | 1 | 2006 | 7322 | 0.100 |
Why?
|
Postoperative Care | 1 | 2018 | 1486 | 0.100 |
Why?
|
Female | 25 | 2023 | 380194 | 0.100 |
Why?
|
Gene Expression | 3 | 2021 | 7799 | 0.100 |
Why?
|
Thoracic Wall | 1 | 2013 | 203 | 0.100 |
Why?
|
Alternative Splicing | 1 | 2016 | 1117 | 0.090 |
Why?
|
Hypothyroidism | 1 | 2016 | 658 | 0.090 |
Why?
|
Postoperative Complications | 4 | 2024 | 15295 | 0.090 |
Why?
|
Perfusion | 3 | 2018 | 1360 | 0.090 |
Why?
|
Workload | 1 | 2016 | 850 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2503 | 0.090 |
Why?
|
Fibroblasts | 2 | 2018 | 4161 | 0.090 |
Why?
|
Osteogenesis | 2 | 2014 | 1299 | 0.090 |
Why?
|
Irritants | 1 | 2009 | 44 | 0.090 |
Why?
|
Perioperative Care | 1 | 2017 | 1002 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2018 | 2969 | 0.090 |
Why?
|
Receptors, Notch | 1 | 2014 | 739 | 0.090 |
Why?
|
Dioxoles | 1 | 2009 | 104 | 0.090 |
Why?
|
Tetrahydroisoquinolines | 1 | 2009 | 91 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2006 | 1504 | 0.080 |
Why?
|
Embryonic Stem Cells | 1 | 2016 | 1294 | 0.080 |
Why?
|
Cell Line | 2 | 2020 | 15997 | 0.080 |
Why?
|
Myostatin | 1 | 2009 | 124 | 0.080 |
Why?
|
Memory Disorders | 1 | 2016 | 1184 | 0.080 |
Why?
|
Skin Ulcer | 1 | 2009 | 120 | 0.080 |
Why?
|
Pilot Projects | 2 | 2018 | 8324 | 0.080 |
Why?
|
Child, Preschool | 6 | 2020 | 41006 | 0.080 |
Why?
|
NF-kappa B | 1 | 2016 | 2499 | 0.080 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 452 | 0.080 |
Why?
|
Epigastric Arteries | 2 | 2023 | 96 | 0.080 |
Why?
|
Earthquakes | 1 | 2010 | 179 | 0.080 |
Why?
|
Patient Preference | 1 | 2015 | 890 | 0.080 |
Why?
|
Soft Tissue Injuries | 1 | 2009 | 176 | 0.080 |
Why?
|
Myocytes, Cardiac | 1 | 2016 | 1637 | 0.080 |
Why?
|
Mesenchymal Stem Cells | 1 | 2018 | 1632 | 0.070 |
Why?
|
International Cooperation | 2 | 2011 | 1420 | 0.070 |
Why?
|
Immunohistochemistry | 5 | 2014 | 11366 | 0.070 |
Why?
|
Reading | 1 | 2011 | 558 | 0.070 |
Why?
|
Cell Differentiation | 3 | 2020 | 11483 | 0.070 |
Why?
|
Cyclic N-Oxides | 1 | 2006 | 78 | 0.070 |
Why?
|
Treatment Outcome | 8 | 2018 | 63114 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1676 | 0.070 |
Why?
|
Burn Units | 2 | 2017 | 136 | 0.070 |
Why?
|
Bariatric Surgery | 1 | 2015 | 952 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2022 | 3920 | 0.070 |
Why?
|
Caspase 9 | 1 | 2005 | 188 | 0.070 |
Why?
|
Spin Labels | 1 | 2006 | 332 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2016 | 2899 | 0.060 |
Why?
|
Leiomyosarcoma | 1 | 2009 | 477 | 0.060 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2004 | 18 | 0.060 |
Why?
|
Emergency Medical Services | 1 | 2016 | 1917 | 0.060 |
Why?
|
Logistic Models | 2 | 2017 | 13408 | 0.060 |
Why?
|
Developing Countries | 3 | 2012 | 2815 | 0.060 |
Why?
|
Catalase | 1 | 2005 | 222 | 0.060 |
Why?
|
Dilatation, Pathologic | 1 | 2006 | 520 | 0.060 |
Why?
|
Organ Culture Techniques | 1 | 2006 | 813 | 0.060 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2005 | 129 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8428 | 0.060 |
Why?
|
Disasters | 1 | 2010 | 511 | 0.060 |
Why?
|
P-Selectin | 1 | 2006 | 600 | 0.060 |
Why?
|
Young Adult | 5 | 2017 | 56430 | 0.060 |
Why?
|
Adolescent | 6 | 2020 | 85781 | 0.060 |
Why?
|
Adult | 10 | 2018 | 214055 | 0.060 |
Why?
|
Patient Satisfaction | 3 | 2013 | 3396 | 0.060 |
Why?
|
RNA, Messenger | 4 | 2006 | 13033 | 0.060 |
Why?
|
Hydrogen Peroxide | 1 | 2006 | 731 | 0.060 |
Why?
|
Reoperation | 3 | 2021 | 4201 | 0.060 |
Why?
|
Caspase 3 | 1 | 2005 | 758 | 0.060 |
Why?
|
Schools | 1 | 2011 | 1433 | 0.050 |
Why?
|
Child | 6 | 2020 | 77709 | 0.050 |
Why?
|
Caspases | 1 | 2005 | 928 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2007 | 1152 | 0.050 |
Why?
|
Drug Implants | 2 | 2018 | 244 | 0.050 |
Why?
|
Fat Necrosis | 2 | 2013 | 58 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2645 | 0.050 |
Why?
|
Aortic Aneurysm | 1 | 2006 | 643 | 0.050 |
Why?
|
DNA Methylation | 1 | 2015 | 4286 | 0.050 |
Why?
|
Injury Severity Score | 2 | 2017 | 1014 | 0.050 |
Why?
|
Students | 1 | 2011 | 1654 | 0.050 |
Why?
|
Staining and Labeling | 1 | 2005 | 1100 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2006 | 972 | 0.050 |
Why?
|
Adipogenesis | 2 | 2014 | 359 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2007 | 3144 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39050 | 0.050 |
Why?
|
PPAR gamma | 1 | 2023 | 493 | 0.050 |
Why?
|
Necrosis | 2 | 2018 | 1643 | 0.050 |
Why?
|
Up-Regulation | 2 | 2006 | 4217 | 0.050 |
Why?
|
Aged | 6 | 2021 | 163280 | 0.050 |
Why?
|
Tamoxifen | 1 | 2005 | 981 | 0.050 |
Why?
|
Muscular Atrophy | 1 | 2023 | 349 | 0.040 |
Why?
|
Neutropenia | 1 | 2005 | 895 | 0.040 |
Why?
|
Registries | 1 | 2015 | 8089 | 0.040 |
Why?
|
Middle Aged | 7 | 2018 | 213383 | 0.040 |
Why?
|
Inflammation | 2 | 2018 | 10638 | 0.040 |
Why?
|
Swine | 2 | 2021 | 5917 | 0.040 |
Why?
|
Transfection | 2 | 2018 | 5892 | 0.040 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2021 | 282 | 0.040 |
Why?
|
Estrogens | 2 | 2022 | 1566 | 0.040 |
Why?
|
Antioxidants | 1 | 2006 | 1663 | 0.040 |
Why?
|
Neovascularization, Physiologic | 2 | 2021 | 1351 | 0.040 |
Why?
|
Down-Regulation | 1 | 2006 | 3002 | 0.040 |
Why?
|
Ink | 1 | 2018 | 44 | 0.040 |
Why?
|
Mice, Obese | 1 | 2018 | 424 | 0.040 |
Why?
|
Asthma | 1 | 2016 | 6011 | 0.040 |
Why?
|
Protein Isoforms | 2 | 2016 | 1730 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 29063 | 0.040 |
Why?
|
Suction | 1 | 2018 | 267 | 0.040 |
Why?
|
Cohort Studies | 2 | 2018 | 40561 | 0.040 |
Why?
|
Tissue Expansion | 1 | 2018 | 162 | 0.040 |
Why?
|
Sodium Salicylate | 1 | 2016 | 19 | 0.040 |
Why?
|
Skin Physiological Phenomena | 1 | 2018 | 180 | 0.040 |
Why?
|
Paracrine Communication | 1 | 2018 | 277 | 0.040 |
Why?
|
Anniversaries and Special Events | 1 | 2017 | 89 | 0.040 |
Why?
|
Biliopancreatic Diversion | 1 | 2015 | 16 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2018 | 1827 | 0.030 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2016 | 104 | 0.030 |
Why?
|
Esthetics | 1 | 2017 | 306 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5788 | 0.030 |
Why?
|
France | 1 | 2017 | 517 | 0.030 |
Why?
|
Receptors, Steroid | 1 | 2016 | 155 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2018 | 11725 | 0.030 |
Why?
|
Platelet-Rich Plasma | 1 | 2018 | 177 | 0.030 |
Why?
|
Program Development | 2 | 2013 | 1316 | 0.030 |
Why?
|
Body Surface Area | 1 | 2015 | 198 | 0.030 |
Why?
|
CA1 Region, Hippocampal | 1 | 2016 | 112 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3282 | 0.030 |
Why?
|
Needs Assessment | 2 | 2012 | 1147 | 0.030 |
Why?
|
Stem Cell Transplantation | 2 | 2014 | 1620 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2007 | 3479 | 0.030 |
Why?
|
Cell Lineage | 2 | 2014 | 2504 | 0.030 |
Why?
|
Cold Temperature | 1 | 2018 | 772 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 2020 | 0.030 |
Why?
|
Macrophages | 2 | 2006 | 5655 | 0.030 |
Why?
|
Infant | 4 | 2020 | 35136 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2016 | 481 | 0.030 |
Why?
|
Protein Stability | 1 | 2016 | 557 | 0.030 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2016 | 377 | 0.030 |
Why?
|
Time | 1 | 2016 | 542 | 0.030 |
Why?
|
Dendritic Spines | 1 | 2016 | 233 | 0.030 |
Why?
|
PAX7 Transcription Factor | 1 | 2014 | 53 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 2016 | 293 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2018 | 1901 | 0.030 |
Why?
|
Trauma Severity Indices | 1 | 2015 | 481 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2017 | 57776 | 0.030 |
Why?
|
Integrin alpha Chains | 1 | 2014 | 97 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2014 | 356 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2016 | 1105 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1842 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2016 | 9734 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10943 | 0.030 |
Why?
|
Pyramidal Cells | 1 | 2016 | 363 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2016 | 346 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2014 | 5974 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2759 | 0.030 |
Why?
|
Efficiency | 1 | 2016 | 462 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2023 | 77449 | 0.030 |
Why?
|
Neutrophils | 1 | 2005 | 3719 | 0.030 |
Why?
|
Sweden | 1 | 2015 | 1345 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2016 | 1202 | 0.030 |
Why?
|
Hydrogels | 1 | 2018 | 724 | 0.030 |
Why?
|
Heart Failure | 1 | 2016 | 10900 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 1116 | 0.030 |
Why?
|
Patient Selection | 2 | 2017 | 4215 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2017 | 2557 | 0.030 |
Why?
|
Cicatrix | 1 | 2018 | 764 | 0.030 |
Why?
|
Homozygote | 1 | 2016 | 1785 | 0.030 |
Why?
|
Work Schedule Tolerance | 1 | 2016 | 565 | 0.030 |
Why?
|
Neoplasms | 1 | 2020 | 21683 | 0.020 |
Why?
|
Burns, Chemical | 1 | 2012 | 159 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1678 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2437 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 72290 | 0.020 |
Why?
|
Hernia, Abdominal | 1 | 2010 | 53 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2618 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2016 | 1178 | 0.020 |
Why?
|
Donor Selection | 1 | 2011 | 201 | 0.020 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2009 | 105 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2014 | 1880 | 0.020 |
Why?
|
Haiti | 1 | 2010 | 553 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 2432 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1889 | 0.020 |
Why?
|
Metabolomics | 1 | 2016 | 1484 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2006 | 21746 | 0.020 |
Why?
|
Cell Separation | 1 | 2014 | 1751 | 0.020 |
Why?
|
Risk Assessment | 3 | 2017 | 23338 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2889 | 0.020 |
Why?
|
Leptin | 1 | 2015 | 1599 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1708 | 0.020 |
Why?
|
Incidence | 2 | 2017 | 20947 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2016 | 14557 | 0.020 |
Why?
|
Surgical Mesh | 1 | 2010 | 276 | 0.020 |
Why?
|
Aorta | 2 | 2005 | 2061 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5882 | 0.020 |
Why?
|
Military Personnel | 1 | 2015 | 1133 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3760 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6489 | 0.020 |
Why?
|
Glucose | 1 | 2018 | 4397 | 0.020 |
Why?
|
Dimerization | 1 | 2007 | 893 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2016 | 25625 | 0.020 |
Why?
|
Cricetulus | 1 | 2007 | 816 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 16689 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2459 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2014 | 2382 | 0.020 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2005 | 56 | 0.020 |
Why?
|
Amitrole | 1 | 2005 | 8 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2009 | 627 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 149 | 0.020 |
Why?
|
CHO Cells | 1 | 2007 | 1406 | 0.020 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 514 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2886 | 0.020 |
Why?
|
Critical Care | 1 | 2017 | 2647 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2012 | 1827 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2274 | 0.020 |
Why?
|
Skin | 1 | 2018 | 4364 | 0.020 |
Why?
|
Device Removal | 1 | 2009 | 656 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4149 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2010 | 969 | 0.010 |
Why?
|
Cricetinae | 1 | 2007 | 2472 | 0.010 |
Why?
|
Echocardiography | 1 | 2016 | 5102 | 0.010 |
Why?
|
Drainage | 1 | 2009 | 1142 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 2005 | 608 | 0.010 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2005 | 288 | 0.010 |
Why?
|
Physician's Role | 1 | 2010 | 943 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4026 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4462 | 0.010 |
Why?
|
Dogs | 1 | 2007 | 3912 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2006 | 20129 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3617 | 0.010 |
Why?
|
Retinal Vessels | 1 | 2007 | 772 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2015 | 3679 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6309 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2007 | 2726 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 7023 | 0.010 |
Why?
|
Low Back Pain | 1 | 2010 | 956 | 0.010 |
Why?
|
Protein Transport | 1 | 2007 | 1988 | 0.010 |
Why?
|
Cost of Illness | 1 | 2011 | 1859 | 0.010 |
Why?
|
Sex Factors | 2 | 2005 | 10397 | 0.010 |
Why?
|
Cell Communication | 1 | 2007 | 1621 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5535 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 12804 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18370 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 2011 | 1876 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16365 | 0.010 |
Why?
|
Health Policy | 1 | 2011 | 2661 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7785 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5179 | 0.010 |
Why?
|
Protein Binding | 1 | 2007 | 9386 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17446 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 29144 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2011 | 5137 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 12745 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2004 | 2958 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15540 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 53288 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29786 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 25043 | 0.010 |
Why?
|